LEO PHARMA INC: Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as
Recall reason: Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.. Recalled by LEO PHARMA INC. Distribution: Nationwide in the USA. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot: a) 003E24C, Exp 04/30/2027; b) 003E24A, Exp 04/30/2027.. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report